Revance Therapeutics Inc. (RVNC)
3.65
0.00 (0.00%)
At close: Feb 05, 2025, 3:59 PM
Revance Therapeutics Stock Forecast
Stock Price Forecast
The 9 analysts with 12-month price forecasts for RVNC stock have an median target of 6, with a low estimate of 3 and a high estimate of 8. The median target predicts an increase of 64.38% from the current stock price of 3.65.
Latest Analyst Insight Report
HC Wainwright & Co. maintains a Neutral rating on ... Unlock content with Pro Subscription
Updated Nov 08, 2024
Financial Forecast this Year
Revenue This Year
250.14M
from 234.04M
Increased by 6.9%
Revenue Next Year
320.07M
from 250.14M
Increased by 28.0%
EPS This Year
-1.14
from -3.83
Increased by 70.2%
EPS Next Year
-0.7
from -1.14
Increased by 38.6%